ANI Pharmaceuticals
ANIP
ANIP
158 hedge funds and large institutions have $320M invested in ANI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 24 closing their positions.
Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
62
Reduced
40
Closed
24
Calls
$2.71M
Puts
$18M
Net Calls
-$15.3M
Net Calls Change
-$12.1M
Top Buyers
| 1 |
1
BlackRock
New York
|
$56M |
| 2 |
2
First Manhattan
New York
|
$13.8M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$8.79M |
| 4 |
KCM
4
Kennedy Capital Management
St Louis,
Missouri
|
$4.07M |
| 5 |
MP
5
Mangrove Partners
Greenwich,
Connecticut
|
$2.89M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SFS
176
Sowell Financial Services
North Little Rock,
Arkansas
| – | – | -8 | Closed |
|
|
AA
177
Ancora Advisors
Cleveland,
Ohio
| – | – | -6 | Closed |
|
|
PFBT
178
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| – | – | -4 | Closed |
|
|
KLI
179
Kelman-Lazarov Inc
Memphis,
Tennessee
| – | – | -1 | Closed |
|
|
WVP
180
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
|
WAM
181
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|
182
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
HCM
183
Highbridge Capital Management
New York
| – | – | – | – |
|
|
AC
184
Alexandria Capital
Arlington,
Virginia
| $0 | 7 | – | – |
|
185
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
TWMP
186
Taylor Wealth Management Partners
Boston,
Massachusetts
| $0 | 10 | – | – |
|
|
DAM
187
DLD Asset Management
New York
| – | – | – | – |
|
188
D.E. Shaw & Co
New York
| – | – | – | – |
|
|
JCM
189
Jacobi Capital Management
Pittston,
Pennsylvania
| $0 | 5 | – | – |
|